ASMC'13 Moscow

5th International Symposium on Advances in Synthetic and Medicinal Chemistry

 Moscow, Russia
May 5-8, 2013    

Confirmed Speakers to date

Synthetic Organic Photochemistry in Batch and Flow

Prof. Kevin BOOKER-MILBURN
Prof. Kevin BOOKER-MILBURN
UNIVERSITY OF BRISTOL, Bristol, United Kingdom
Read more

Making Molecular Prosthetics via Iterative Cross-Coupling with MIDA Boronates

Prof. Martin D. BURKE
Prof. Martin D. BURKE
UNIVERSITY OF ILLINOIS, Urbana, United States
Read more

Oligonucleotide Synthesis Interfaced with Molecular Biology and Nanotechnology

Prof. Marvin CARUTHERS
Prof. Marvin CARUTHERS
UNIVERSITY OF COLORADO, Boulder, United States
Read more

BETting on Epigenetic Targets : From Phenotypic Discovery to First Time in Man

Dr Chun-wa CHUNG
Dr Chun-wa CHUNG
GLAXOSMITHKLINE, Stevenage, United Kingdom
Read more

Versatile Synthetic Methods: Access to Bioactive Molecules

Prof. Janine COSSY
Prof. Janine COSSY
ESPCI PARISTECH, Paris, France
Read more

Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture

Dr Simona COTESTA
Dr Simona COTESTA
NOVARTIS, Basel, Switzerland
Read more

Highly Anti-inflammatory Dendritic Polyglycerol Sulfates - a Multiple Target Approach

Prof. Rainer HAAG
Prof. Rainer HAAG
FREE UNIVERSITY BERLIN, Berlin, Germany
Read more

Targeting Protein Surfaces Using Designed Proteomimetics

Prof. Andrew HAMILTON
Prof. Andrew HAMILTON
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

A New Approach to Tuberculosis Research: The Lilly TB Drug Discovery Initiative

Dr Philip A. HIPSKIND
Dr Philip A. HIPSKIND
ELI LILLY & COMPANY, Indianapolis, United States
Read more

Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to the Clinical Candidate AZD7687

Dr Petra JOHANNESSON
Dr Petra JOHANNESSON
ASTRAZENECA, Mölndal, Sweden
Read more

Harnessing Synergy Between Natural Products and Synthesis Towards Drug Discovery

Prof. Goverdhan MEHTA
Prof. Goverdhan MEHTA
UNIVERSITY OF HYDERABAD, Hyderabad, India
Read more

New Strategies in Organic Synthesis: Recent Advances Based on Catalytic Reactions of Boron Reagents

Prof. James P. MORKEN
Prof. James P. MORKEN
BOSTON COLLEGE, Chestnut Hill, United States
Read more

P2X Receptors: ATP-Gated Ion Channels as Novel Drug Targets

Prof. Christa MÜLLER
Prof. Christa MÜLLER
UNIVERSITY OF BONN, Bonn, Germany
Read more

Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules

Dr Antonio NARDI
Dr Antonio NARDI
GRÜNENTHAL, Aachen, Germany
Read more

Organic Molecules as Biological Probes...an exciting journey

Prof. Cristina NEVADO
Prof. Cristina NEVADO
UNIVERSITY OF ZURICH, Zurich, Switzerland
Read more

Bitopertin (RG1678), a Potent and Selective Glycine Re-Uptake Inhibitor for the Treatment of Schizophrenia

Dr Emmanuel PINARD
Dr Emmanuel PINARD
F. HOFFMANN-LA ROCHE, Basel, Switzerland
Read more

Antibody Drug Conjugates for the Treatment of Cancer

Dr Paul POLAKIS
Dr Paul POLAKIS
GENENTECH, San Francisco, United States
Read more

Peptide Chemologics

Dr Lee ROBERTS
Dr Lee ROBERTS
PFIZER, Sandwich, United Kingdom
Read more

The Discovery of the Macrocyclic HCV NS3/4A Protease Inhibitor MK-5172

Dr Michael ROWLEY
Dr Michael ROWLEY
MERCK RESEARCH LABORATORIES, Kriens, Switzerland
Read more

The Design and Characterization of Targeted Covalent Inhibitors of Btk

Dr Eric SCHWARTZ
Dr Eric SCHWARTZ
CELGENE AVILOMICS RESEARCH, Cambridge, United States
Read more

From Organic Synthesis to Biomedical Sciences - from Polyhydroxybutyrate (PHB) to Cell-Penetrating Peptides

Prof. Dieter SEEBACH
Prof. Dieter SEEBACH
ETH ZURICH, Zürich, Switzerland
Read more

Engineering of Small Non-Antibody Protein Scaffolds as Novel Biopharmaceuticals: from Anticalins to PASylation

Prof. Arne SKERRA
Prof. Arne SKERRA
TECHNICAL UNIVERSITY MUNICH, München, Germany
Read more

Metal Catalyzed Arylation of Nucleophiles

Dr Marc TAILLEFER
Dr Marc TAILLEFER
ENSCM, Montpellier, France
Read more

Discovery and Initial Clinical Results of [18F]-UCB-H, First PET Radiotracer Targeting Synaptic Vesicle 2A

Dr Anne VALADE
Dr Anne VALADE
UCB, Braine-l'Alleud, Belgium
Read more

Confirmed Oral Communications

EFMC Prize for a Young Medicinal Chemist in Academia
Chemical Approaches to Biology and Therapeutics

Prof. Gonçalo BERNARDES
Prof. Gonçalo BERNARDES
INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL & UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom
Read more

EFMC Prize for a Young Medicinal Chemist in Industry
Free-Wilson and Structural Approaches to Co-Optimising Human and Rodent Isoform Potency for 11β-Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors

Dr Frederick GOLDBERG
Dr Frederick GOLDBERG
ASTRAZENECA, Macclesfield, United Kingdom
Read more

Novel Synthetic Chemical Chaperones as a New Basis For Amyotrophic Lateral Sclerosis (ALS) Treatment

Prof. Arie-Lev GRUZMAN
Prof. Arie-Lev GRUZMAN
BAR ILAN UNIVERSITY, Ramat Gan, Israel
Read more

New Inhibitors of the Enzyme Isoprenylcysteine Carboxyl Methyltransferase (ICMT)

Prof. María del Mar MARTÍN-FONTECHA
Prof. María del Mar MARTÍN-FONTECHA
COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain
Read more

Fragment-Based Design of Inhibitors of The Antituberculotic Target 1-Deoxy-D-Xylulose-5-Phosphate Synthase Exploiting an Innovative Combination of NMR Techniques

Mrs Tiziana MASINI
Mrs Tiziana MASINI
UNIVERSITY OF GRONINGEN, Groningen, The Netherlands
Read more

Design, Synthesis and Application Of Fluorinated Amino Acids as Labels to Study the Membrane Active Peptides by Solid State 19F NMR

Dr Pavel MYKHAILIUK
Dr Pavel MYKHAILIUK
ENAMINE LTD, Kyiv, Ukraine
Read more

Rapid Kinase SAR Generation: an Integrated Approach to Synthesis, Screening and Molecular Design

Dr David PARRY
Dr David PARRY
CYCLOFLUIDIC LTD, United Kingdom
Read more

Virtual Screening and Design of New Pharmaceutical Agents Using PASS Approach

Prof. Vladimir POROIKOV
Prof. Vladimir POROIKOV
INSTITUTE OF BIOMEDICAL CHEMISTRY, Moscow, Russia
Read more

Discovery of Highly Potent S1P1 Receptor Antagonists with in vivo Efficacy

Dr Jean QUANCARD
Dr Jean QUANCARD
NOVARTIS, Basel, Switzerland
Read more

Self-Immolative Spacers in Prodrug/Profluorophore Strategies: Determination of Kinetic Parameters for Release of Single or Multiple Substrates.

Dr Frédéric SCHMIDT
Dr Frédéric SCHMIDT
INSTITUT CURIE, Paris, France
Read more

Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors

Dr Graeme SMITH
Dr Graeme SMITH
VERTEX PHARMACEUTICALS, Cambridge, United States
Read more

Synthetic Approach to Novel Melatonin Receptor Ligands

Mrs Maria VOLKOVA
Mrs Maria VOLKOVA
MOSCOW STATE UNIVERSITY, CHEMISTRY DEPARTMENT, Moscow, Russia
Read more